PACIFIC BIOSCIENCES ...
Display and export data
General & Ratios
Financial Statements
/
In the 'original' view, the statements are displayed just as they are being reported by the company.
In the 'standardised' view, the statements are displayed in a standardised format (line items are identical for all companies).
Add data
Click on one of the orange fields in the profile to add new information
Edit or review data
Legend (for Financial Statements)
Passed value check (?)
Failed value check (?)
Click on a coloured field in the profile to review the data
Close sidebar
Loading: 100%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 438 (as per Q2 2015)no data available
Sector Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available
Ticker PACBno data available
Financial year endsFY ends End of no data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 170,02,55,07,510,0
datesClosing price (adj.)
13.10.20174.47
11.10.20174.50
04.10.20175.17
27.09.20175.25
20.09.20175.39
13.09.20175.39
06.09.20175.22
30.08.20174.81
23.08.20174.29
16.08.20174.23
09.08.20173.97
02.08.20173.20
26.07.20173.33
19.07.20173.34
12.07.20173.50
05.07.20173.58
27.06.20173.58
20.06.20173.31
13.06.20173.45
06.06.20173.43
30.05.20173.46
23.05.20173.83
16.05.20174.13
09.05.20173.97
02.05.20174.00
25.04.20175.03
18.04.20174.88
11.04.20175.07
04.04.20175.18
28.03.20174.85
21.03.20174.66
14.03.20174.64
07.03.20174.83
28.02.20175.05
21.02.20175.17
14.02.20175.21
07.02.20174.76
31.01.20174.82
24.01.20174.53
17.01.20174.78
10.01.20175.01
03.01.20174.36
27.12.20163.90
19.12.20164.05
12.12.20166.84
05.12.20166.94
28.11.20167.71
21.11.20167.87
14.11.20168.26
07.11.20167.29
31.10.20168.50
24.10.20168.99
17.10.20168.50
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
 4.47n/a
Market Capitalisation
in million USD
 390n/a
Enterprise Value
in million USD
 313n/a
Common Shares Outstanding
as per Apr 30, 2016
 87,168,677n/a
Preferred Shares Outstanding
as per Apr 30, 2016
 n/a
Average Basic Shares Outstanding
TTM
 77,977,750n/a
Average Diluted Shares Outstanding
TTM
 n/a
Index Membership
n/a
Business Summary
Pacific Biosciences of California Inc is a biotechnology company. It is engaged in design, development and manufacture of sequencing system to help scientists resolve genetically complex problems.
no data available
Key Financials & Ratios (all figures TTM as per Nov 30, -1, million USD, full statements further below)
Profit & Loss
Revenues 94n/a
Gross Profit 57n/a
Operating Income -51n/a
EBITDA -48n/a
Net Profit -31n/a
Balance Sheet
Cash and Cash Equivalents 92n/a
Receivables 8n/a
Total Current Assets 119n/a
PP&E 9n/a
Total Assets 140n/a
Accounts Payable 5n/a
Current Debt 0n/a
Total Current Liabilities 32n/a
Long-Term Debt 15n/a
Total Liabilities 51n/a
Total Equity 89n/a
Cash Flow
Depreciation & Amortisation 4n/a
Change in Working Capital -30n/a
Operating Cash Flow -44n/a
Net Change in PP&E and Intangibles -3n/a
Investing Cash Flow -30n/a
Dividends Paid 0n/a
Financing Cash Flow 64n/a
Total Change in Cash -10n/a
Free Cash Flow -80n/a
Profitability Ratios
Gross Margin 60.5%n/a
Operating Margin -54.5%n/a
Net Profit Margin -32.8%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS -0.40n/a
Diluted EPS n/a
Sales per Share 1.21n/a
Book Value per Share n/a
FCF per Share -1.03n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio -11.29n/a
Price to Sales Ratio 3.70n/a
Price to Book Value n/a
Price to Free Cash Flow -4.33n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.23n/a
Other Ratios
Current Ratio 371.9%n/a
Liabilities to Equity Ratio 57.9%n/a
Debt to Assets Ratio 10.9%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
0
2
34
26
28
61
93
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
0
0
-21
-25
-22
-37
-39
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
0
2
13
1
6
23
53
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-88
-142
-123
-95
-84
-86
-106
Selling, General & Administrative
-12
-30
-47
-48
-39
-38
-45
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
-76
-112
-76
-48
-45
-48
-60
Depreciation & Amortization
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
-88
-140
-110
-94
-78
-63
-52
Non-Operating Income (Loss)
0
0
0
0
-2
-3
-3
Interest Expense, net
0
0
0
0
-2
-3
-3
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
1
0
1
0
0
Pretax Income (Loss), Adjusted
-88
-140
-109
-94
-79
-66
-55
Abnormal Gains (Losses)
0
0
0
0
0
0
23
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
-88
-140
-109
-94
-79
-66
-32
Income Tax (Expense) Benefit, net
0
0
0
0
0
0
0
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-88
-140
-109
-94
-79
-66
-32
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-88
-140
-109
-94
-79
-66
-32
Minority Interest
0
0
0
0
0
0
0
Net Income
-88
-140
-109
-94
-79
-66
-32
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-88
-140
-109
-94
-79
-66
-32
Remarks
restated on Mar 1, 2012 n/a
calculated values,
restated on Mar 15, 2013 n/a
calculated values,
restated on Mar 14, 2014 n/a
calculated values,
restated on Mar 12, 2015 n/a
calculated values,
restated on Mar 11, 2016 n/a
calculated values,
restated on Mar 11, 2016 n/a
calculated values,
restated on Mar 11, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
284
177
101
113
101
82
Cash & Cash Equivalents
n/a
148
59
47
26
36
34
Short Term Investments
n/a
136
119
54
86
65
49
Accounts & Notes Receivable
n/a
0
5
3
3
3
5
Accounts Receivable, Net
n/a
0
5
3
3
3
5
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
7
16
10
10
11
11
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
2
2
2
1
2
12
Prepaid Expenses
n/a
2
2
2
1
2
12
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
Total Current Assets
n/a
293
200
115
126
118
111
Property, Plant & Equipment, Net
n/a
12
18
14
9
7
9
Property, Plant & Equipment
n/a
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
0
0
0
0
0
12
Intangible Assets
n/a
0
0
0
0
0
0
Goodwill
n/a
0
0
0
0
0
0
Other Intangible Assets
n/a
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
0
0
0
0
0
12
Total Noncurrent Assets
n/a
13
19
15
10
7
21
Total Assets
n/a
306
218
130
136
124
131
Liabilities and owners' equity
Payables & Accruals
n/a
10 9515000
5 4742000
3 2988000
10 9622000
17 17049000
20 20300000
Accounts Payable
n/a
10 9515000
5 4742000
3 2988000
2 1717000
6 5608000
5 4749000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
0 0
0 0
0 0
8 7905000
11 11441000
16 15551000
Short Term Debt
n/a
0 110000
0 140000
0 173000
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
11 11215000
14 14494000
12 11582000
13 12933000
14 14440000
18 17878000
Deferred Revenue
n/a
3 3221000
4 4236000
3 3378000
11 10831000
13 12906000
18 17637000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
8 7994000
10 10258000
8 8204000
2 2102000
2 1534000
0 241000
Total Current Liabilities
n/a
21 20840000
19 19376000
15 14743000
23 22555000
31 31489000
38 38178000
Long Term Debt
n/a
0 0
0 0
0 0
13 13347000
14 13991000
15 14948000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
5 5041000
7 7477000
6 5558000
31 31103000
24 23961000
4 4441000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
1 549000
1 944000
1 600000
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
5 5041000
7 7477000
6 5558000
31 30554000
23 23017000
4 3841000
Total Noncurrent Liabilities
n/a
5 5041000
7 7477000
6 5558000
44 44450000
38 37952000
19 19389000
Total Liabilities
n/a
26 25881000
27 26853000
20 20301000
67 67005000
69 69441000
58 57567000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
612 612054000
633 632961000
645 645372000
684 684479000
736 736413000
787 786716000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-332 -332167000
-442 -441555000
-536 -536020000
-615 -615313000
-681 -681473000
-713 -713169000
Other Equity
n/a
0 -21000
0 57000
0 30000
0 14000
0 9000
0 -7000
Equity Before Minority Interest
n/a
280 279866000
191 191463000
109 109382000
69 69180000
55 54949000
74 73540000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
280 279866000
191 191463000
109 109382000
69 69180000
55 54949000
74 73540000
Total Liabilities & Equity
n/a
306 305747000
218 218316000
130 129683000
136 136185000
124 124390000
131 131107000
Remarks restated on n/a restated on Mar 1, 2012 n/a restated on Mar 15, 2013 n/a restated on Mar 14, 2014 n/a restated on Mar 12, 2015 n/a restated on Mar 11, 2016 n/a restated on May 5, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
-88
-140
-109
-94
-79
-66
-32
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
4
5
6
7
6
4
4
Non-Cash Items
4
10
13
11
10
11
12
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
5
3
-12
0
34
-1
-31
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
-75
-122
-103
-77
-30
-51
-48
Change in Fixed Assets & Intangibles
-5
-5
-9
-2
-1
-2
-3
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
24
-133
16
63
-32
21
16
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
0
-5
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
19
-138
6
62
-33
20
9
Dividends Paid
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
67
106
0
0
20
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
213
8
3
23
42
36
Increase in Capital Stock
0
213
8
3
23
42
36
Decrease in Capital Stock
0
0
0
0
0
0
0
Other Financing Activities
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
67
319
8
3
43
42
36
Net Cash Before Disc. Operations and FX
11
58
-89
-12
-20
10
-3
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
11
58
-89
-12
-20
10
-3
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
Net Changes in Cash
11
58
-89
-12
-20
10
-3
Remarks
restated on Mar 1, 2012 n/a
calculated values,
restated on Mar 15, 2013 n/a
calculated values,
restated on Mar 14, 2014 n/a
calculated values,
restated on Mar 12, 2015 n/a
calculated values,
restated on Mar 11, 2016 n/a
calculated values,
restated on Mar 11, 2016 n/a
calculated values,
restated on Mar 11, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
About | Contact Forum | Legal
SimFin UG 2017 - Beta v. 1.42
Facebook | Twitter | Medium
Sumo